Bryan, Garnier & Co grows its Healthcare franchise with the hiring of Dr Anne Moore
PARIS, October 9, 2017 – Bryan, Garnier & Co, the leading pan-European Investment Bank focusing on growth companies, is delighted to welcome Dr Anne Moore to its European Healthcare franchise.
With over 10 years of global experience in investment banking and management consulting, Anne, an American/French citizen, will be responsible for the origination and execution of ECM and M&A mandates for European growth healthcare companies, as well as participate in leveraging Bryan, Garnier & Co’s healthcare practice and track record. She will be based in Paris.
Prior to joining Bryan, Garnier & Co, Anne spent eight years in New York working in management consulting, market research and investment banking, with organizations such as Bionest Partners and Credit Suisse. She advised from mid-sized biotech and med-tech companies to larger pharma companies such as Abbvie, Pfizer, Biogen, AstraZeneca.
Before this, she worked in management consulting in Paris, helping start-ups build growth strategies and governmental actors /patients associations make investment decisions. She also advised on entry strategies into Europe for North American companies and conducting strategic due diligence for investment funds.
Hervé Ronin, Partner, Paris comments: “I am delighted to have Anne join us. Our healthcare activities continue to grow fast and her hiring follows several additions to our European healthcare team in our London and Munich offices. Anne brings valuable experience in the healthcare space and will strengthen our coverage of and service offering to top European healthcare companies”.
Anne Moore adds: “Bryan, Garnier & Co has an outstanding track-record with growth healthcare companies. Back from New York, I was looking to put my biotech/pharma industry knowledge to good use in a dynamic, global investment bank. Combining customer dedication and a “can-do” state-of-mind, Bryan, Garnier and Co ticked all the boxes – I am very much looking forward to my future career here”.
Anne holds a PhD in Human Genetics and Physiology from the Paris XII University and an Advanced Master in Biotechnology Management from Toulouse Business School.